rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.

BACKGROUND: For effective control of visceral leishmaniasis (VL) in East Africa, new rapid diagnostic tests are required to replace current tests with low sensitivity. The aim of this study is to improve diagnosis of VL in East Africa by testing a new antigen from an autochthonous L. donovani strain...

Full description

Bibliographic Details
Main Authors: Elfadil Abass, Nadine Bollig, Katharina Reinhard, Bärbel Camara, Durria Mansour, Alexander Visekruna, Michael Lohoff, Ulrich Steinhoff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3715527?pdf=render
_version_ 1819098178999287808
author Elfadil Abass
Nadine Bollig
Katharina Reinhard
Bärbel Camara
Durria Mansour
Alexander Visekruna
Michael Lohoff
Ulrich Steinhoff
author_facet Elfadil Abass
Nadine Bollig
Katharina Reinhard
Bärbel Camara
Durria Mansour
Alexander Visekruna
Michael Lohoff
Ulrich Steinhoff
author_sort Elfadil Abass
collection DOAJ
description BACKGROUND: For effective control of visceral leishmaniasis (VL) in East Africa, new rapid diagnostic tests are required to replace current tests with low sensitivity. The aim of this study is to improve diagnosis of VL in East Africa by testing a new antigen from an autochthonous L. donovani strain in Sudan. METHODOLOGY AND PRINCIPLE FINDINGS: We cloned, expressed and purified a novel recombinant protein antigen of L. donovani from Sudan, designated rKLO8, that contains putative conserved domains with significant similarity to the immunodominant kinesin proteins of Leishmania. rKLO8 exhibited 93% and 88% amino acid identity with cloned kinesin proteins of L. infantum (synonymous L. chagasi) (K39) and L. donovani (KE16), respectively. We evaluated the diagnostic efficiency of the recombinant protein in ELISA for specific detection of VL patients from Sudan. Data were compared with a rK39 ELISA and two commercial kits, the rK39 strip test and the direct agglutination test (DAT). Of 106 parasitologically confirmed VL sera, 104 (98.1%) were tested positive by rKLO8 as compared to 102 (96.2%) by rK39. Importantly, the patients' sera showed increased reactivity with rKLO8 than rK39. Specificity was 96.1% and 94.8% for rKLO8- and rK39 ELISAs, respectively. DAT showed 100% specificity and 94.3% sensitivity while rK39 strip test performed with 81.1% sensitivity and 98.7% specificity. CONCLUSION: The increased reactivity of Sudanese VL sera with the rKLO8 makes this antigen a potential candidate for diagnosis of visceral leishmaniasis in Sudan. However, the suitability at the field level will depend on its performance in a rapid test format.
first_indexed 2024-12-22T00:26:52Z
format Article
id doaj.art-a7a17382d93d49ae9e9551d2a0d1fc1b
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-22T00:26:52Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-a7a17382d93d49ae9e9551d2a0d1fc1b2022-12-21T18:45:02ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352013-01-0177e232210.1371/journal.pntd.0002322rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.Elfadil AbassNadine BolligKatharina ReinhardBärbel CamaraDurria MansourAlexander VisekrunaMichael LohoffUlrich SteinhoffBACKGROUND: For effective control of visceral leishmaniasis (VL) in East Africa, new rapid diagnostic tests are required to replace current tests with low sensitivity. The aim of this study is to improve diagnosis of VL in East Africa by testing a new antigen from an autochthonous L. donovani strain in Sudan. METHODOLOGY AND PRINCIPLE FINDINGS: We cloned, expressed and purified a novel recombinant protein antigen of L. donovani from Sudan, designated rKLO8, that contains putative conserved domains with significant similarity to the immunodominant kinesin proteins of Leishmania. rKLO8 exhibited 93% and 88% amino acid identity with cloned kinesin proteins of L. infantum (synonymous L. chagasi) (K39) and L. donovani (KE16), respectively. We evaluated the diagnostic efficiency of the recombinant protein in ELISA for specific detection of VL patients from Sudan. Data were compared with a rK39 ELISA and two commercial kits, the rK39 strip test and the direct agglutination test (DAT). Of 106 parasitologically confirmed VL sera, 104 (98.1%) were tested positive by rKLO8 as compared to 102 (96.2%) by rK39. Importantly, the patients' sera showed increased reactivity with rKLO8 than rK39. Specificity was 96.1% and 94.8% for rKLO8- and rK39 ELISAs, respectively. DAT showed 100% specificity and 94.3% sensitivity while rK39 strip test performed with 81.1% sensitivity and 98.7% specificity. CONCLUSION: The increased reactivity of Sudanese VL sera with the rKLO8 makes this antigen a potential candidate for diagnosis of visceral leishmaniasis in Sudan. However, the suitability at the field level will depend on its performance in a rapid test format.http://europepmc.org/articles/PMC3715527?pdf=render
spellingShingle Elfadil Abass
Nadine Bollig
Katharina Reinhard
Bärbel Camara
Durria Mansour
Alexander Visekruna
Michael Lohoff
Ulrich Steinhoff
rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
PLoS Neglected Tropical Diseases
title rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
title_full rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
title_fullStr rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
title_full_unstemmed rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
title_short rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.
title_sort rklo8 a novel leishmania donovani derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in sudan
url http://europepmc.org/articles/PMC3715527?pdf=render
work_keys_str_mv AT elfadilabass rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT nadinebollig rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT katharinareinhard rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT barbelcamara rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT durriamansour rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT alexandervisekruna rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT michaellohoff rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan
AT ulrichsteinhoff rklo8anovelleishmaniadonovaniderivedrecombinantimmunodominantproteinforsensitivedetectionofvisceralleishmaniasisinsudan